SARS-CoV-2 vaccination and phase 1 cancer clinical trials

Affiliations

• ¹ Investigational Cancer Therapeutics (Phase I Program), University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: tyap@mdanderson.org.
• ² Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
• ³ Early Phase Clinical Drug Development in Oncology, START Madrid-CIOCC, Centro Integral Oncológico Clara Campal, Madrid, Spain.
• ⁴ Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, Netherlands.
• ⁵ Early Phase Clinical Trials Program, Yale University Medical Center, New Haven, CT, USA.
• ⁶ Department of Drug Development, Gustave Roussy Cancer Institute, University Paris Saclay, Villejuif, France.
• ⁷ Northern Institute for Cancer Care, Freeman Hospital and Newcastle University, Newcastle upon Tyne, UK.
• ⁸ The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK.
• ⁹ Department of Medical Oncology, Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Barcelona, Spain.